Intended Audience
This activity is designed for the fellow in training, the practitioner of medical oncology who wishes to review both established standards of care and recent basic and clinical advances in medical oncology, or the physician planning to take the medical oncology certifying examination.
Topics & Speakers
- Pathology of Lymphomas
L. Jeffrey Medeiros, MD
Professor and Chair, Department of Hematopathology, MD Anderson Cancer Center, Houston, TX
- Non-Hodgkin’s Lymphoma
- Hodgkin’s Disease
Julie Vose, MD
Neumann M. and Mildred E. Harris Professor, Chief, Section of Hematology and Oncology, Professor of Medicine, Nebraska Medical School, Omaha, NE
- Chronic Lymphocytic Leukemia
Susan O’Brien, MD
Professor of Medicine, UT MD Anderson Cancer Center, Houston, TX
- Acute Lymphocytic Leukemia
- Chronic Myeloid Leukemia
Hagop Kantarjian, MD
Professor of Medicine, Department of Leukemia, MD Anderson Cancer Center/Tumor Institute, Houston, TX
- Multiple Myeloma, Plasmacytoma, MGUS
S. Vincent Rajkumar, MD
Professor of Medicine, Division of Hematology, Mayo Clinic, Rochester, MN
- Waldenstom’s Macroglobulinemia and Amyloidosis
Morie A. Gertz, MD
Professor of Medicine, Division of Hematology, Mayo Clinic, Rochester, MN
- Myelodysplasia
Alan F. List, MD
Professor of Medicine and Chief, Hematologic Malignancies, H. Lee Moffitt Cancer Center, Tampa, FL
- Morphology Review
Donald Karcher, MD
Professor and Acting Chair of Pathology, The George Washington University Medical Center, Washington, DC
- Bone Marrow Transplantation
Michael Bishop, MD
Rockville, MD
- ABO Incompatibility and Other Transfusion Related Issues in Hematopoietic Transplantation
Charles D. Bolan, MD
Director, Hematology Fellowship Program, Hematology Branch, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD
- Pharmacology I, II, and III
Edward Chu, MD
Professor and Chief, Section of Medical Oncology, Associate Director, Yale Cancer Center, Yale University School of Medicine, New Haven, CT
- HIV Disease
Richard Little, MD
Oncologist, Bethesda, MD
- Neuro-Oncology
- Metastatic Disease to the Brain, Spine and
Carcinomatous Meningitis
Howard Fine, MD
Graduate of University of Pennsylvania, Philadelphia, PA; Graduate of Mount Sinai School of Medicine, New York, NY; Chief, Neuro-Oncology Branch, National Cancer Institute (NCI), National Institutes of Health (NIH); Adjunct Investigator, National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH); Adjunct Professor, North Carolina State University; and Adjunct Professor, The George Washington University School of Medicine and Health Sciences
- Head and Neck Cancer
David J. Adelstein, MD
Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, and Staff Physician, Department of Solid Tumor Oncology, Cleveland Clinic Taussig Cancer Center, Cleveland, OH
- Non-Small Cell Lung Cancer
- Small Cell Lung Cancer
Bruce E. Johnson, MD
Program Director, Lowe Center for Thoracic Oncology, Lowe Center for Thoracic Oncology, Dana Farber Cancer Institute, Boston, MA
- Bone Health in Cancer
Harold A. Harvey, MD
Professor of Medicine, Division of Hematology/Oncology, Penn State Milton S. Hershey Medical Center, Penn State College of Medicine, Hershey, PA
- Endocrine Malignancies
Joshua L. Cohen, MD
Associate Professor of Medicine, Division of Endocrinology and Metabolism, The George Washington University Medical Center, Washington, DC
- Adjuvant Therapy for Breast Cancer
William J. Gradishar, MD
Professor, Division of Hematology/Oncology, Northwestern University Medical Center, Chicago, IL
|
- Treatment of Metastatic Breast Cancer
Claudine Isaacs, MD
Associate Professor of Medicine and Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC
- Expert Panel: Problems in Treating Breast Cancer
Drs. Gradishar, Isaacs and Siegel
- Melanoma
Lynn Schucter, MD
Professor of Medicine, Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA
- Esophageal Cancer
Susan G. Urba, MD
Professor, Department of Internal Medicine, University of Michigan, Ann Arbor, MI
- Familial Cancer Syndromes
Judy Garber, MD, MPH
Professor, Department of Internal Medicine, University of Michigan, Ann Arbor, MI
- Testicular Cancer and Mediastinal Germ Cell Tumors
Patrick J. Loehrer, MD
Director and Bruce Kenneth Wiseman Professor of Medicine, Department of Hematology/Oncology,
Indiana University School of Medicine, Indianapolis, IN
- Renal Cell Cancer
- Bladder Cancer
Dean Bajorin, MD
Attending Physician and Member, Genitourinary Oncology Services, Memorial Sloan-Kettering Cancer Center, Professor of Medicine, Weil Medical College of Cornell University, New York, NY
- Prostrate Cancer
Philip Kantoff, MD
Professor of Medicine, Harvard Medical School, Chief, Division of Solid Tumor Oncology, Dana
Farber Cancer Institute, Boston, MA
- Ovarian Cancer
- Endometrial Tumors
J. Tate Thigpen, MD
Professor of Medicine and Director, Division of Medical Oncology, University of Mississippi Medical Center, Jackson, MS
- Trophoblastic Tumors
- Cancer of the Cervix, Vagina, Vulva
Daniel Clarke-Pearson, MD
Robert A. Ross Distinguished Professor and Chairman, Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, NC
- Sarcomas
Richard Carvajal, MD
Instructor in Medicine, Weill Cornell Medical College, Assistant Attending Physician, Memorial Sloan-Kettering Cancer Center, New York, NY
- Gastric Cancer
- Rectal Cancer: Therapy by Stage and Treatment of Advanced Disease
- Anal Cancer
John Macdonald, MD
Chief Medical Officer, Aptium Oncology, Inc., New York, NY
- Pancreatic Cancer
- Mesothelioma
Hedy Lee Kindler, MD
Associate Professor of Medicine, Director, Gastrointestinal Oncology, Director, Mesothelioma Program, University of Chicago, Chicago, IL
- Small Bowel Cancer
- Carcinoid
James D. Ahlgren, MD
Professor of Medicine, Division of Hematology and Medical Oncology, The George Washington University Medical Center, Washington, DC
- Adjuvant Therapy for Colon Cancer
- Hepatobiliary Cancer
Daniel Haller, MD
Professor of Medicine, Abramson Cancer Center of the University of Pennsylvania Medical Center,
Philadelphia, PA
- Metastatic Colon Cancer
John Marshall, MD
Associate Professor of Medicine Division of Hematology/Oncology, Lombardi Comprehensive Cancer Center, Washington, DC
- Infectious Disease
Afsoon Roberts, MD
Associate Professor of Medicine, Department of Medicine-Division of Infectious Diseases, The George Washington University Medical Center, Washington, DC
- Palliative Care
Amy P. Abernethy, MD
Associate Professor of Medicine, Duke University Medical Center, Durham, NC
|
Learning Objectives
After viewing this activity, participants should be able to:
- Be familiar with the diagnosis, evaluation, and management of hematologic malignancies
- Understand the most recent advances in the pharmacology and toxicology of anti-neoplastic drugs
- Understand the epidemiology of malignant diseases and management of the medical complications of malignancy
- Recognize the latest advances in cancers of the lung, the breast, and the gastrointestinal tract
- Understand the principals of management of gynecologic and other genito-urinary malignancies
- Contend with complexity of HIV related malignancies
- Recognize principles of new developments in biologic therapy of cancer
Accreditation
The George Washington University Medical Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essential Areas, Elements and Policies.
CME Credit
The George Washington University Medical Center designates the Medical Oncology Best Practices for a maximum of 35 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Date of original release: December 1, 2009
Expiration Date: December 1, 2012
The Learning Process
Physician learners are expected to view/listen to all modules, reflect on their content, complete the CME self-assessment and CME evaluation, and return them to the address indicated for scoring. A $30 processing fee must accompany the completed self-assessment and evaluation. Only upon receipt of your self-assessment, evaluation and payment will your CME certificate and correct answers to the self-assessment be mailed to you.
The estimated time a learner will need to complete this self-study activity is
35 hours.
Method of Physician Participation: Review recordings of conference sessions and apply knowledge to post-test.
Evaluation Methods: Participants will complete a self-assessment examination to test knowledge gained from viewing the program.
Notice
The content of this program is developed independently by GW’s Hematology/Medical Oncology Board Review course director, who has no special knowledge or access to American Board of Internal Medicine examinations. The ABIM is not affiliated with,
nor does it endorse, any continuing medical education programs.
|
